Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis

被引:30
作者
Huang, Weihuan [1 ]
Liang, Yeyin [1 ]
Wang, Jiajian [1 ]
Li, Guoqiang [1 ]
Wang, Guocai [1 ]
Li, Yaolan [1 ]
Chung, Hau Yin [2 ]
机构
[1] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Coll Pharm, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China
[2] Chinese Univ Hong Kong, Sch Life Sci, Food & Nutr Sci Programme, Shatin, Hong Kong, Peoples R China
关键词
Wedelia chinensis; Kaurane diterpenoid; Anti-angiogenesis; Zerbrafish; Mechanism; VEGF; GROWTH; CANCER; INFLAMMATION; PATHWAY;
D O I
10.1016/j.phymed.2015.12.021
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Background: Wedelia chinensis is a traditional medicinal herb used in Asia and it has been reported to possess various bioactivities including anti-inflammatory and anticancer effects. However, its anti-angiogenic activity has never been reported. Purpose: To determine the most potent anti-angiogenic component in W. chinensis and its molecular mechanism of action. Study design: Initially, the active fraction of the plant was studied. Then, we determined the active components of the fraction and explored the mechanism of the most active compound. Methods: The ethanol extract of W. chinensis and its four fractions with different polarities were evaluated for their anti-angiogenic activity in the Zebrafish model using quantitative endogenous alkaline phosphatase (EAP) assay. The molecular mechanism of the most active compound from the active fraction was studied using the real-time polymerase chain reaction (PCR) assay on Zebrafish embryos. The inhibitory effect of the most active compound on the proliferation, invasion and tube formation steps of angiogenesis was evaluated using the vascular endothelial growth factor (VEGF)-induced human umbilical vein endothelial cells (HUVECs) model, and the influences of the active compound on tyrosine phosphorylation of VEGF receptor (VEGFR-2) and its downstream signal pathway were evaluated by western blotting assay. Moreover, its anti-angiogenic effect was further evaluated by the VEGF-induced sprouts formation on aortic ring assay and the VEGF-induced vessel formation of mice on matrigel plug assay, respectively. Results: Petroleum ether (PE) fraction of the plant displayed potent anti-angiogenic activity. Twelve kaurane diterpenoids (1-12) isolated from this fraction showed quite different effects. Compounds 9-12 could dose-dependently inhibit vessel formation in the Zebrafish embryos while the others showed little inhibitory effect. Among the active diterpenoids, compound 10, 3 alpha-cinnamoyloxy-9 beta-hydroxy-ent-kaura-16-en-19-oic acid (CHKA), possessed the strongest effect, and it affected multiple molecular targets related to angiogenesis including VEGF and angiopoietin in Zerbrafish. Moreover, CHKA significantly inhibited a series of VEGF-induced angiogenesis processes including proliferation, invasion, and tube formation of endothelial cells. Besides, it directly inhibited VEGFR-2 tyrosine kinase activity and its downstream signaling pathways in HUVECs. CHKA also obviously inhibited sprouts formation of aortic ring, and block vessel formation in mice. Conclusion: Our findings demonstrate that kaurane diterpenoids is one of anti-angiogenic components in W. chinensis, and CHKA may become a promising candidate for the development of anti-angiogenic agent. (C) 2016 Elsevier GmbH. All rights reserved.
引用
收藏
页码:283 / 292
页数:10
相关论文
共 29 条
[1]
Pathways connecting inflammation and cancer [J].
Allavena, Paola ;
Garlanda, Cecilia ;
Borrello, Maria Grazia ;
Sica, Antonio ;
Mantovani, Alberto .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) :3-10
[2]
Combined anti-proliferative and anti-angiogenic strategies for cancer [J].
Bar, Jair ;
Onn, Amir .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (05) :701-715
[3]
NATURALLY-OCCURRING TERPENE DERIVATIVES .300. EUDESMANOLIDES AND DITERPENES FROM WEDELIA-TRILOBATA AND AN ENT-KAURENIC ACID-DERIVATIVE FROM ASPILIA-PARVIFOLIA [J].
BOHLMANN, F ;
ZIESCHE, J ;
KING, RM ;
ROBINSON, H .
PHYTOCHEMISTRY, 1981, 20 (04) :751-756
[4]
Angiogenesis: What can it offer for future medicine? [J].
Cao, Yihai .
EXPERIMENTAL CELL RESEARCH, 2010, 316 (08) :1304-1308
[5]
VEGF-targeted therapy: mechanisms of anti-tumour activity [J].
Ellis, Lee M. ;
Hicklin, Daniel J. .
NATURE REVIEWS CANCER, 2008, 8 (08) :579-591
[6]
The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[7]
ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[8]
Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins [J].
Gingras, D ;
Lamy, S ;
Béliveau, R .
BIOCHEMICAL JOURNAL, 2000, 348 (02) :273-280
[9]
Anti-angiogenic effects and mechanisms of zerumin A from Alpinia caerulea [J].
He, Zhi-Heng ;
Gilli, Christian ;
Yue, Grace Gar-Lee ;
Lau, Clara Bik-San ;
Greger, Harald ;
Brecker, Lothar ;
Ge, Wei ;
But, Paul Pui-Hay .
FOOD CHEMISTRY, 2012, 132 (01) :201-208
[10]
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis [J].
Hicklin, DJ ;
Ellis, LM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (05) :1011-1027